Project Grant R01EY036648
Award Date
9/30/24
Completion Date
7/31/27
Dollars Obligated
$425K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
This Project Grant award for $684,891.00 was provided by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867). The award to the Massachusetts Eye and Ear Infirmary, a non-profit hospital and research center affiliated with Harvard Medical School, will fund research to address the challenge of interpreting rare genetic variants of unknown significance in inherited retinal degenerations. The project aims to develop a high-throughput splicing assay to...
This federal Project Grant award of $715,098 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) aims to enhance glaucoma risk prediction through advanced genomics and machine learning. The key products and services to be delivered include: Improving polygenic risk score (PRS) performance for glaucoma by leveraging natural language processing techniques and electronic health record data from over 68,000 patients to extract refined glaucoma phenotypes. The...
This $185,000 Project Grant award from the National Eye Institute (NEI) under CFDA 93.867 (Vision Research) supports research to discover novel disease-modifying therapies for the prevention and treatment of glaucoma. The primary awardee, the University of North Texas Health Science Center at Fort Worth, will employ computational pharmacology approaches to identify small molecule inhibitors that can interfere with the GREM1-BMP protein-protein interaction, a key pathogenic mechanism contributing...
The National Eye Institute (NEI) awarded a $679,159 Project Grant (CFDA 93.867 - Vision Research) to The Schepens Eye Research Institute, Inc. to investigate the combined effects of aging and elevated intraocular pressure (IOP) on the development of glaucoma and the retinal ganglion cell (RGC) transcriptome. The research aims to: 1) Demonstrate that elevated IOP-induced glaucoma is more severe in aging mice and that transient AAV2-OSK (Oct4, Sox2, Klf4) mediated epigenetic reprogramming can...
The National Eye Institute (NEI) awarded a $813,213 Project Grant (CFDA 93.867 - Vision Research) to the Icahn School of Medicine at Mount Sinai to conduct a multiomic analysis of preclinical biomarkers for primary open-angle glaucoma (POAG). The 5-year research project will analyze proteomic and metabolomic profiles in plasma samples from a matched case-control group nested within prospective health studies, along with genetic and clinical data, to better understand POAG pathophysiology and...
The National Eye Institute (NEI) has awarded a $592,457 Project Grant (CFDA 93.867 - Vision Research) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to characterize the response features of intrinsically photosensitive retinal ganglion cells (ipRGCs) and understand how they shape signals sent from ipRGCs to the brain. The award period is from September 30, 2024 to August 31, 2029. The research aims to strengthen the basic understanding of ipRGCs, sensory...
The National Eye Institute (NEI) awarded a $250,500 Project Grant (CFDA 93.867 - Vision Research) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "A ONE AND DONE THERAPEUTIC STRATEGY TO CORRECT ELP1 SPLICING DEFECT IN FAMILIAL DYSAUTONOMIA". The objective is to develop a genome editing approach to correct the splicing mutation that causes Familial Dysautonomia, a neurodegenerative disorder, with the goal of rescuing retinal...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is providing $481,250 to Vanderbilt University Medical Center to investigate the role of the ADAMTS10 gene in the development of glaucoma. The grant aims to define the mechanism by which ADAMTS10 promotes transforming growth factor beta (TGF-β) signaling, and test the hypothesis that reduced TGF-β signaling resulting from glaucoma-causing ADAMTS10 mutations leads to...
This federal Project Grant award, provided by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), will support research to investigate the genetic and epigenetic mechanisms underlying retinal development and vision disorders. The total funding amount is $1,241,223, with a project period from September 1, 2024 to March 31, 2029. The research aims to provide a deep understanding of the chromatin-based regulatory mechanisms that govern retinal transcription programs...
This federal Project Grant award of $362,415 from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports research to investigate the role of the orexin neurotransmitter system in regulating intraocular pressure (IOP) and its potential implications for glaucoma treatment. The research aims to: 1) examine the influence of the brainstem raphe pallidus on IOP elevations induced by stimulation of the dorsomedial hypothalamus/perifornical region, 2) assess the...